Stay updated on INTRUST: Urelumab/Nivolumab Combo Clinical Trial
Sign up to get notified when there's something new on the INTRUST: Urelumab/Nivolumab Combo Clinical Trial page.

Latest updates to the INTRUST: Urelumab/Nivolumab Combo Clinical Trial page
- Check4 days agoChange DetectedThe page revision/version label was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check11 days agoChange DetectedCorrected the author name in the Sci Transl Med reference from Muhammed to Muhammad. Updated the revision from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check40 days agoChange DetectedAdded a 2026 Clin Cancer Res publication on intratumoral urelumab with nivolumab; removed the earlier Clin Cancer Res citation (online ahead of print).SummaryDifference0.1%

- Check47 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check76 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. This appears to be an internal version update and does not alter study content or user-facing information.SummaryDifference0.0%

- Check83 days agoChange DetectedAdditions include two literature references and a revision notice, while deletions remove the corresponding errata and an earlier revision note; these changes affect bibliographic context but do not modify study design, eligibility criteria, or primary outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to INTRUST: Urelumab/Nivolumab Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INTRUST: Urelumab/Nivolumab Combo Clinical Trial page.